GB9917777D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
GB9917777D0
GB9917777D0 GBGB9917777.6A GB9917777A GB9917777D0 GB 9917777 D0 GB9917777 D0 GB 9917777D0 GB 9917777 A GB9917777 A GB 9917777A GB 9917777 D0 GB9917777 D0 GB 9917777D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9917777.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9917777.6A priority Critical patent/GB9917777D0/en
Publication of GB9917777D0 publication Critical patent/GB9917777D0/en
Priority to CNB008133603A priority patent/CN1213740C/en
Priority to JP2001513396A priority patent/JP4902918B2/en
Priority to ARP000103891A priority patent/AR024966A1/en
Priority to DK00953110.4T priority patent/DK1204410T3/en
Priority to ES00953110T priority patent/ES2392393T3/en
Priority to NZ516733A priority patent/NZ516733A/en
Priority to BR0012869-4A priority patent/BR0012869A/en
Priority to KR1020027001225A priority patent/KR100710118B1/en
Priority to CZ2002336A priority patent/CZ2002336A3/en
Priority to US10/049,227 priority patent/US7163693B1/en
Priority to PCT/EP2000/007295 priority patent/WO2001008666A1/en
Priority to PL353308A priority patent/PL208550B1/en
Priority to CA2391707A priority patent/CA2391707C/en
Priority to TR2002/00258T priority patent/TR200200258T2/en
Priority to HU0201936A priority patent/HUP0201936A3/en
Priority to AU65676/00A priority patent/AU773800B2/en
Priority to MXPA02001080A priority patent/MXPA02001080A/en
Priority to EP00953110A priority patent/EP1204410B1/en
Priority to IL14782600A priority patent/IL147826A0/en
Priority to CO00056905A priority patent/CO5190660A1/en
Priority to MYPI20003465 priority patent/MY125298A/en
Priority to TW089115294A priority patent/TWI236915B/en
Priority to IL147826A priority patent/IL147826A/en
Priority to NO20020464A priority patent/NO332155B1/en
Priority to HK02107581.8A priority patent/HK1047537A1/en
Priority to US11/611,281 priority patent/US7691407B2/en
Priority to US12/689,015 priority patent/US8440224B2/en
Priority to NO20120271A priority patent/NO20120271L/en
Ceased legal-status Critical Current

Links

GBGB9917777.6A 1999-07-30 1999-07-30 Pharmaceutical formulation Ceased GB9917777D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GBGB9917777.6A GB9917777D0 (en) 1999-07-30 1999-07-30 Pharmaceutical formulation
IL14782600A IL147826A0 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
TR2002/00258T TR200200258T2 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
AU65676/00A AU773800B2 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
HU0201936A HUP0201936A3 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
DK00953110.4T DK1204410T3 (en) 1999-07-30 2000-07-27 PHARMACEUTICAL DOSAGE FORM WITH MULTIPLE COMPONENTS
JP2001513396A JP4902918B2 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
NZ516733A NZ516733A (en) 1999-07-30 2000-07-27 Pharmaceutical formulations for oral dosing that are dosage forms comprising two or more connected sub-units
BR0012869-4A BR0012869A (en) 1999-07-30 2000-07-27 Multi-component Pharmaceutical Dosage Form
KR1020027001225A KR100710118B1 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
CZ2002336A CZ2002336A3 (en) 1999-07-30 2000-07-27 Multicomponent pharmaceutical dosage form
US10/049,227 US7163693B1 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
PCT/EP2000/007295 WO2001008666A1 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
MXPA02001080A MXPA02001080A (en) 1999-07-30 2000-07-27 Multicomponent pharmaceutical dosage form.
CA2391707A CA2391707C (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
CNB008133603A CN1213740C (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
ARP000103891A AR024966A1 (en) 1999-07-30 2000-07-27 PHARMACEUTICAL FORMULATION
ES00953110T ES2392393T3 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
PL353308A PL208550B1 (en) 1999-07-30 2000-07-27 Multi−component pharmaceutical dosage form
EP00953110A EP1204410B1 (en) 1999-07-30 2000-07-27 Multi-component pharmaceutical dosage form
MYPI20003465 MY125298A (en) 1999-07-30 2000-07-28 Multi-component pharmaceutical dosage form
CO00056905A CO5190660A1 (en) 1999-07-30 2000-07-28 PHARMACEUTICAL FORMULATION INCLUDE TWO OR MORE CONNECTED UNITS
TW089115294A TWI236915B (en) 1999-07-30 2000-10-18 Capsule with multi-component multi-unit dosage compartments and process for making same
IL147826A IL147826A (en) 1999-07-30 2002-01-24 Multi-component pharmaceutical dosage form
NO20020464A NO332155B1 (en) 1999-07-30 2002-01-29 Multi-component pharmaceutical dosage form and preparation thereof
HK02107581.8A HK1047537A1 (en) 1999-07-30 2002-10-17 Multi-component pharmaceutical dosage form
US11/611,281 US7691407B2 (en) 1999-07-30 2006-12-15 Multi-component pharmaceutical dosage form
US12/689,015 US8440224B2 (en) 1999-07-30 2010-01-18 Multi-component pharmaceutical dosage form
NO20120271A NO20120271L (en) 1999-07-30 2012-03-09 Multi-component pharmaceutical dosage form and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9917777.6A GB9917777D0 (en) 1999-07-30 1999-07-30 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
GB9917777D0 true GB9917777D0 (en) 1999-09-29

Family

ID=10858134

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9917777.6A Ceased GB9917777D0 (en) 1999-07-30 1999-07-30 Pharmaceutical formulation

Country Status (1)

Country Link
GB (1) GB9917777D0 (en)

Similar Documents

Publication Publication Date Title
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
AU4328800A (en) Pharmaceutical formulation
EP1173216A4 (en) Pharmaceutical formulations
GB9818927D0 (en) Pharmaceutical formulation
IL148543A0 (en) Pharmaceutical carrier formulation
GB9909154D0 (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation
GB9926251D0 (en) Pharmaceutical formulation
GB9930578D0 (en) Pharmaceutical formulations
GB9906126D0 (en) Pharmaceutical formulations
GB9817470D0 (en) Pharmaceutical formulation
GB9802617D0 (en) Pharmaceutical formulation
GB9930700D0 (en) Pharmaceutical formulation
GB9917774D0 (en) Pharmaceutical formulation
GB9917777D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation
GB9910636D0 (en) Pharmaceutical formulation
GB9917772D0 (en) Pharmaceutical formulation
GB9930878D0 (en) Pharmaceutical formulation
GB9927685D0 (en) Pharmaceutical formulation
GB9922187D0 (en) Pharmaceutical formulation
GB9917775D0 (en) Pharmaceutical formulation
GB9919840D0 (en) Pharmaceutical formulation
GB9921396D0 (en) Pharmaceutical formulation
EP1414417A4 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)